Related references
Note: Only part of the references are listed.Financial Toxicity During Breast Cancer Treatment: A Qualitative Analysis to Inform Strategies for Mitigation
Laila A. Gharzai et al.
JCO ONCOLOGY PRACTICE (2021)
Assessing the financial toxicity in Tunisian cancer patients using the Comprehensive Score for Financial Toxicity (COST)
Nesrine Mejri et al.
SUPPORTIVE CARE IN CANCER (2021)
Measuring financial toxicity in Australian cancer patients - Validation of the COmprehensive Score for financial Toxicity (FACT COST) measuring financial toxicity in Australian cancer patients
Kimberley Durber et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2021)
Crowdsourcing to measure financial toxicity in gynecologic oncology
Katharine M. Esselen et al.
GYNECOLOGIC ONCOLOGY (2021)
Cross-sectional study to develop and describe psychometric characteristics of a patient-reported instrument (PROFFIT) for measuring financial toxicity of cancer within a public healthcare system
Silvia Riva et al.
BMJ OPEN (2021)
Financial toxicity in patients with gynecologic malignancies: a cross sectional study
Burak Zeybek et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2021)
Cost-effectiveness of pembrolizumab compared with chemotherapy in the US for women with previously treated deficient mismatch repair or high microsatellite instability unresectable or metastatic endometrial cancer
Elizabeth Thurgar et al.
JOURNAL OF MEDICAL ECONOMICS (2021)
Financial toxicity and its associated patient and cancer factors among women with breast cancer: a single-center analysis of low-middle income region in China
Jingfeng Jing et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Financial toxicity in gynecologic oncology
Sara Bouberhan et al.
GYNECOLOGIC ONCOLOGY (2019)
Prospective Survey of Financial Toxicity Measured by the Comprehensive Score for Financial Toxicity in Japanese Patients With Cancer
Kazunori Honda et al.
JOURNAL OF GLOBAL ONCOLOGY (2019)
A prospective survey of comprehensive score for financial toxicity in Japanese cancer patients: report on a pilot study
Kazunori Honda et al.
ECANCERMEDICALSCIENCE (2018)
Measuring financial toxicity as a clinically relevant patient-reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST)
Jonas A. de Souza et al.
CANCER (2017)
The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy
F. Perrone et al.
ANNALS OF ONCOLOGY (2016)
Self-reported financial burden of cancer care and its effect on physical and mental health-related quality of life among US cancer survivors
Hrishikesh P. Kale et al.
CANCER (2016)
Financial Insolvency as a Risk Factor for Early Mortality Among Patients With Cancer
Scott D. Ramsey et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Comparison of Value Set Based on DCE and/or TTO Data: Scoring for EQ-5D-5L Health States in Japan
Takeru Shiroiwa et al.
VALUE IN HEALTH (2016)
Financial Distress and Its Associations With Physical and Emotional Symptoms and Quality of Life Among Advanced Cancer Patients
Marvin Delgado-Guay et al.
ONCOLOGIST (2015)
The Development of a Financial Toxicity Patient-Reported Outcome in Cancer The COST Measure
Jonas A. de Souza et al.
CANCER (2014)
2014 FIGO staging for ovarian, fallopian tube and peritoneal cancer Clinical comment
David G. Mutch et al.
GYNECOLOGIC ONCOLOGY (2014)
FIGO staging for carcinoma of the vulva, cervix, and corpus uteri
H. Belhadj et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2014)
The Financial Toxicity of Cancer Treatment: A Pilot Study Assessing Out-of-Pocket Expenses and the Insured Cancer Patient's Experience
S. Yousuf Zafar et al.
ONCOLOGIST (2013)
Share Paper
